Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001952693 | SCV002208614 | uncertain significance | Myofibrillar myopathy 4 | 2021-04-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu540*) in the LDB3 gene. The LDB3 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_007078.3, and corresponds to NM_001080116.1:c.*17339G>T in the primary transcript. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in LDB3 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with LDB3-related conditions. This variant is not present in population databases (ExAC no frequency). |
Fulgent Genetics, |
RCV002484650 | SCV002788428 | uncertain significance | Dilated cardiomyopathy 1C; Myofibrillar myopathy 4 | 2021-10-13 | criteria provided, single submitter | clinical testing |